Medical College of Wisconsin
CTSIResearch InformaticsREDCap

Publications indexed to the term Platelet Activation

FacultyTitle
1Chronic diseases alter the platelet rheostat to promote hyperreactivity and thrombosis. (Silverstein RL) J Clin Invest 2025 Aug 15;135(16)       1 Citation
1PF4-dependent P-selectin expression assay in comparison to the heparin-induced platelet activation assay for the diagnosis of heparin-induced thrombocytopenia. (Meier RT, Jolink AT, Kempe M, Curtis BR, Hofstede-van Egmond S, de Haas M, Porcelijn L, Kapur R) Transfusion 2025 May;65(5):848-850    
2Glycosphingolipids and their impact on platelet activity in a murine model of fabry disease. (Kanack AJ, Prodoehl E, Ishihara-Aoki M, Aoki K, Dahms NM) Sci Rep 2024 Nov 27;14(1):29488       1 Citation
4Prothrombotic antibodies targeting the spike protein's receptor-binding domain in severe COVID-19. (Zhu W, Zheng Y, Yu M, Witman N, Zhou L, Wei J, Zhang Y, Topchyan P, Nguyen C, Wang D, Janecke R, Padmanabhan A, Baumann Kreuziger L, White GC, Hari P, Gu T, Fields AT, Kornblith LZ, Aster R, Zhu J, Cui W, Jobe S, Graham MB, Wang D, Wen R) Blood 2025 Feb 06;145(6):635-647       4 Citations
1Alterations in visible light exposure modulate platelet function and regulate thrombus formation. (Andraska EA, Denorme F, Kaltenmeier C, Arivudainabi A, Mihalko EP, Dyer M, Annarapu GK, Zarisfi M, Loughran P, Ozel M, Williamson K, Mota Alvidrez RI, Thomas K, Shiva S, Shea SM, Steinman RA, Campbell RA, Rosengart MR, Neal MD) J Thromb Haemost 2025 Jan;23(1):123-138       2 Citations
1Editorial: The immunological role of platelet activation in the pathophysiology of COVID-19. (Rossouw TM, Pretorius E, Wool GD) Front Immunol 2023;14:1285355    
2PACSIN2 regulates platelet integrin β1 hemostatic function. (Biswas R, Boyd EK, Eaton N, Steenackers A, Schulte ML, Reusswig F, Yu H, Drew C, Kahr WHA, Shi Q, Plomann M, Hoffmeister KM, Falet H) J Thromb Haemost 2023 Dec;21(12):3619-3632       1 Citation
1Effect of P2Y12 Inhibitors on Survival Free of Organ Support Among Non-Critically Ill Hospitalized Patients With COVID-19: A Randomized Clinical Trial. (Berger JS, Kornblith LZ, Gong MN, Reynolds HR, Cushman M, Cheng Y, McVerry BJ, Kim KS, Lopes RD, Atassi B, Berry S, Bochicchio G, de Oliveira Antunes M, Farkouh ME, Greenstein Y, Hade EM, Hudock K, Hyzy R, Khatri P, Kindzelski A, Kirwan BA, Baumann Kreuziger L, Lawler PR, Leifer E, Lopez-Sendon Moreno J, Lopez-Sendon J, Luther JF, Nigro Maia L, Quigley J, Sherwin R, Wahid L, Wilson J, Hochman JS, Neal MD, ACTIV-4a Investigators) JAMA 2022 Jan 18;327(3):227-236       114 Citations
1Multicentre evaluation of 5B9, a monoclonal anti-PF4/heparin IgG mimicking human HIT antibodies, as an internal quality control in HIT functional assays: Communication from the ISTH SSC Subcommittee on Platelet Immunology. (Pouplard C, Rollin J, Vayne C, Charuel N, Ahmadi Z, Alberio L, Azjenberg N, Althaus K, Bakchoul T, Chong B, Curtis BR, Faille D, Gomez FJ, Gresele P, Morel-Kopp MC, Mullier F, Nazy I, Smith JW, Greinacher A, Gruel Y) J Thromb Haemost 2022 Jan;20(1):252-259       10 Citations
1Bleeding diathesis in mice lacking JAK2 in platelets. (Eaton N, Subramaniam S, Schulte ML, Drew C, Jakab D, Haberichter SL, Weiler H, Falet H) Blood Adv 2021 Aug 10;5(15):2969-2981    
2Platelet and myeloid cell phenotypes in a rat model of Fabry disease. (Kanack AJ, Aoki K, Tiemeyer M, Dahms NM) FASEB J 2021 Aug;35(8):e21818       4 Citations
1Post-Translational Modifications of Platelet-Derived Amyloid Precursor Protein by Coagulation Factor XIII-A. (Hur WS, Juang LJ, Mazinani N, Munro L, Jefferies WA, Kastrup CJ) Biochemistry 2020 Nov 24;59(46):4449-4455       7 Citations
4Cysteine sulfenylation by CD36 signaling promotes arterial thrombosis in dyslipidemia. (Yang M, Li W, Harberg C, Chen W, Yue H, Ferreira RB, Wynia-Smith SL, Carroll KS, Zielonka J, Flaumenhaft R, Silverstein RL, Smith BC) Blood Adv 2020 Sep 22;4(18):4494-4507       30 Citations
1RGS10 and RGS18 differentially limit platelet activation, promote platelet production, and prolong platelet survival. (DeHelian D, Gupta S, Wu J, Thorsheim C, Estevez B, Cooper M, Litts K, Lee-Sundlov MM, Hoffmeister KM, Poncz M, Ma P, Brass LF) Blood 2020 Oct 08;136(15):1773-1782       21 Citations
6Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding. (Zwifelhofer NMJ, Bercovitz RS, Cole R, Yan K, Simpson PM, Moroi A, Newman PJ, Niebler RA, Scott JP, Stuth EAD, Woods RK, Benson DW, Newman DK) Thromb Haemost 2020 Jan;120(1):94-106       21 Citations
1Dynamin 2 is required for GPVI signaling and platelet hemostatic function in mice. (Eaton N, Drew C, Wieser J, Munday AD, Falet H) Haematologica 2020 May;105(5):1414-1423       8 Citations
1CD36 and ERK5 link dyslipidemia to apoptotic-like platelet procoagulant function. (Yang M, Silverstein RL) Curr Opin Hematol 2019 Sep;26(5):357-365       16 Citations
2Diacylglycerol kinase ζ is a negative regulator of GPVI-mediated platelet activation. (Moroi AJ, Zwifelhofer NM, Riese MJ, Newman DK, Newman PJ) Blood Adv 2019 Apr 09;3(7):1154-1166       9 Citations
1CD36 signaling in vascular redox stress. (Yang M, Silverstein RL) Free Radic Biol Med 2019 May 20;136:159-171       55 Citations
1Platelet CD36 signaling through ERK5 promotes caspase-dependent procoagulant activity and fibrin deposition in vivo. (Yang M, Kholmukhamedov A, Schulte ML, Cooley BC, Scoggins NO, Wood JP, Cameron SJ, Morrell CN, Jobe SM, Silverstein RL) Blood Adv 2018 Nov 13;2(21):2848-2861       63 Citations
1Platelets loaded with liposome-encapsulated thrombin have increased coagulability. (Chan V, Sarkari M, Sunderland R, St John AE, White NJ, Kastrup CJ) J Thromb Haemost 2018 Jun;16(6):1226-1235       21 Citations
1Csk/CD148 and platelet SFK activation: a balancing act! (Zhu J) Blood 2018 Mar 08;131(10):1042-1043       6 Citations
2Normal plasma IgG inhibits HIT antibody-mediated platelet activation: implications for therapeutic plasma exchange. (Jones CG, Pechauer SM, Curtis BR, Bougie DW, Aster RH, Padmanabhan A) Blood 2018 Feb 08;131(6):703-706       23 Citations
1Refrigeration-Induced Binding of von Willebrand Factor Facilitates Fast Clearance of Refrigerated Platelets. (Chen W, Druzak SA, Wang Y, Josephson CD, Hoffmeister KM, Ware J, Li R) Arterioscler Thromb Vasc Biol 2017 Dec;37(12):2271-2279       47 Citations
1The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosis. (Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, Ng C, Zhang W, Neeves KB, Lentz SR, Wang X, Frye SV, Shelton Earp H 3rd, DeRyckere D, Brass LF, Graham DK, Di Paola JA) J Thromb Haemost 2018 Feb;16(2):352-363       27 Citations
1Kindlin supports platelet integrin αIIbβ3 activation by interacting with paxillin. (Gao J, Huang M, Lai J, Mao K, Sun P, Cao Z, Hu Y, Zhang Y, Schulte ML, Jin C, Wang J, White GC, Xu Z, Ma YQ) J Cell Sci 2017 Nov 01;130(21):3764-3775       54 Citations
1Immunopathological response to severe injury: platelet activation and the Th-17 immune response. (Morris RS, Schaffer BS, Lundy JB, Pidcoke HF, Chung KK, Darlington DN, Cap AP, Schwacha MG) Blood Coagul Fibrinolysis 2018 Jan;29(1):48-54       9 Citations
1Platelet activation and erythrocyte lysis during brief exposure of blood to pathophysiological shear stress in vitro. (Majumdar S, Patil CN, Ladner-Threadgill T, Randolph E, Burgreen GW, Kermode JC) Clin Hemorheol Microcirc 2017;67(2):159-172       7 Citations
1Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. (Kastelowitz N, Tamura R, Onasoga A, Stalker TJ, White OR, Brown PN, Brodsky GL, Brass LF, Branchford BR, Di Paola J, Yin H) Sci Rep 2017 Jun 27;7(1):4275       16 Citations
1Decreased thromboembolic stroke but not atherosclerosis or vascular remodelling in mice with ROCK2-deficient platelets. (Sladojevic N, Oh GT, Kim HH, Beaulieu LM, Falet H, Kaminski K, Freedman JE, Liao JK) Cardiovasc Res 2017 Sep 01;113(11):1307-1317       26 Citations
3Platelet CD36 promotes thrombosis by activating redox sensor ERK5 in hyperlipidemic conditions. (Yang M, Cooley BC, Li W, Chen Y, Vasquez-Vivar J, Scoggins NO, Cameron SJ, Morrell CN, Silverstein RL) Blood 2017 May 25;129(21):2917-2927       88 Citations
1Localization of Short-Chain Polyphosphate Enhances its Ability to Clot Flowing Blood Plasma. (Yeon JH, Mazinani N, Schlappi TS, Chan KY, Baylis JR, Smith SA, Donovan AJ, Kudela D, Stucky GD, Liu Y, Morrissey JH, Kastrup CJ) Sci Rep 2017 Feb 10;7:42119       11 Citations
1Integrin-αIIbβ3-mediated outside-in signalling activates a negative feedback pathway to suppress platelet activation. (Dai B, Wu P, Xue F, Yang R, Yu Z, Dai K, Ruan C, Liu G, Newman PJ, Gao C) Thromb Haemost 2016 Oct 28;116(5):918-930       15 Citations
1Metabolic Manipulation to Put the Brakes on Platelet Activation: A Potential Novel Pharmacologic Approach to Atherothrombosis. (Silverstein RL) Arterioscler Thromb Vasc Biol 2016 Oct;36(10):2031-2    
3A whole blood model of thrombocytopenia that controls platelet count and hematocrit. (Bercovitz RS, Brenner MK, Newman DK) Ann Hematol 2016 Oct;95(11):1887-94       9 Citations
2Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice. (Baumgartner CK, Mattson JG, Weiler H, Shi Q, Montgomery RR) J Thromb Haemost 2017 Jan;15(1):98-109       22 Citations
1Intracellular Trafficking, Localization, and Mobilization of Platelet-Borne Thiol Isomerases. (Crescente M, Pluthero FG, Li L, Lo RW, Walsh TG, Schenk MP, Holbrook LM, Louriero S, Ali MS, Vaiyapuri S, Falet H, Jones IM, Poole AW, Kahr WH, Gibbins JM) Arterioscler Thromb Vasc Biol 2016 Jun;36(6):1164-73       56 Citations
3A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis. (Padmanabhan A, Jones CG, Curtis BR, Bougie DW, Sullivan MJ, Peswani N, McFarland JG, Eastwood D, Wang D, Aster RH) Chest 2016 Sep;150(3):506-15       86 Citations
4Platelet Activation and Thrombus Formation over IgG Immune Complexes Requires Integrin αIIbβ3 and Lyn Kinase. (Zhi H, Dai J, Liu J, Zhu J, Newman DK, Gao C, Newman PJ) PLoS One 2015;10(8):e0135738       32 Citations
2A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Thromb Haemost 2015 Nov 25;114(6):1322-3       26 Citations
2CLEC-2: the inside story. (Newman DK) Blood 2015 Jun 25;125(26):3972-4       3 Citations
3Restoration of responsiveness of phospholipase Cγ2-deficient platelets by enforced expression of phospholipase Cγ1. (Zheng Y, Adams T, Zhi H, Yu M, Wen R, Newman PJ, Wang D, Newman DK) PLoS One 2015;10(3):e0119739       13 Citations
1New approaches to inhibiting platelets and coagulation. (Depta JP, Bhatt DL) Annu Rev Pharmacol Toxicol 2015;55:373-97       40 Citations
3Heparin-independent, PF4-dependent binding of HIT antibodies to platelets: implications for HIT pathogenesis. (Padmanabhan A, Jones CG, Bougie DW, Curtis BR, McFarland JG, Wang D, Aster RH) Blood 2015 Jan 01;125(1):155-61       76 Citations
1Exosome poly-ubiquitin inhibits platelet activation, downregulates CD36 and inhibits pro-atherothombotic cellular functions. (Srikanthan S, Li W, Silverstein RL, McIntyre TM) J Thromb Haemost 2014 Nov;12(11):1906-17       119 Citations
1Direct interaction of kindlin-3 with integrin αIIbβ3 in platelets is required for supporting arterial thrombosis in mice. (Xu Z, Chen X, Zhi H, Gao J, Bialkowska K, Byzova TV, Pluskota E, White GC 2nd, Liu J, Plow EF, Ma YQ) Arterioscler Thromb Vasc Biol 2014 Sep;34(9):1961-7       43 Citations
1Proteasome proteolysis supports stimulated platelet function and thrombosis. (Gupta N, Li W, Willard B, Silverstein RL, McIntyre TM) Arterioscler Thromb Vasc Biol 2014 Jan;34(1):160-8       52 Citations
1Sitosterolemia: platelets on high-sterol diet. (Falet H) Blood 2013 Oct 10;122(15):2534-5       4 Citations
1Lipopolysaccharide stimulates platelets through an IL-1β autocrine loop. (Brown GT, Narayanan P, Li W, Silverstein RL, McIntyre TM) J Immunol 2013 Nov 15;191(10):5196-203       116 Citations
2Platelet hyperreactivity explains the bleeding abnormality and macrothrombocytopenia in a murine model of sitosterolemia. (Kanaji T, Kanaji S, Montgomery RR, Patel SB, Newman PJ) Blood 2013 Oct 10;122(15):2732-42       61 Citations
1CD39 target practice. (Newman DK) Blood 2013 Apr 18;121(16):3061-2       1 Citation
1Functional genomics of the human high-density lipoprotein receptor scavenger receptor BI: an old dog with new tricks. (Chadwick AC, Sahoo D) Curr Opin Endocrinol Diabetes Obes 2013 Apr;20(2):124-31       13 Citations
2Protamine-induced immune thrombocytopenia. (Singla A, Sullivan MJ, Lee G, Bartholomew J, Kapadia S, Aster RH, Curtis BR) Transfusion 2013 Oct;53(10):2158-63       25 Citations
2Platelet signaling. (Stalker TJ, Newman DK, Ma P, Wannemacher KM, Brass LF) Handb Exp Pharmacol 2012(210):59-85       146 Citations
1von Willebrand factor (VWF) propeptide binding to VWF D'D3 domain attenuates platelet activation and adhesion. (Madabhushi SR, Shang C, Dayananda KM, Rittenhouse-Olson K, Murphy M, Ryan TE, Montgomery RR, Neelamegham S) Blood 2012 May 17;119(20):4769-78       28 Citations
1Polymorphism in the protease-activated receptor-4 gene region associates with platelet activation and perioperative myocardial injury. (Muehlschlegel JD, Perry TE, Liu KY, Fox AA, Smith SA, Lichtner P, Collard CD, Shernan SK, Hartwig JH, Body SC, Hoffmeister KM) Am J Hematol 2012 Feb;87(2):161-6       15 Citations
2A newly identified complex of spinophilin and the tyrosine phosphatase, SHP-1, modulates platelet activation by regulating G protein-dependent signaling. (Ma P, Cierniewska A, Signarvic R, Cieslak M, Kong H, Sinnamon AJ, Neubig RR, Newman DK, Stalker TJ, Brass LF) Blood 2012 Feb 23;119(8):1935-45       54 Citations
5Residues within a lipid-associated segment of the PECAM-1 cytoplasmic domain are susceptible to inducible, sequential phosphorylation. (Paddock C, Lytle BL, Peterson FC, Holyst T, Newman PJ, Volkman BF, Newman DK) Blood 2011 Jun 02;117(22):6012-23       38 Citations
1Vav guanine nucleotide exchange factors link hyperlipidemia and a prothrombotic state. (Chen K, Li W, Major J, Rahaman SO, Febbraio M, Silverstein RL) Blood 2011 May 26;117(21):5744-50       62 Citations
4Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. (Gao C, Boylan B, Fang J, Wilcox DA, Newman DK, Newman PJ) Blood 2011 May 05;117(18):4946-52       120 Citations
1P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. (Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R, Gear AR, Linden J) Arterioscler Thromb Vasc Biol 2010 Dec;30(12):2392-9       159 Citations
2Mechanism of outside-in {alpha}IIb{beta}3-mediated activation of human platelets by the colonizing Bacterium, Streptococcus gordonii. (Keane C, Petersen H, Reynolds K, Newman DK, Cox D, Jenkinson HF, Newman PJ, Kerrigan SW) Arterioscler Thromb Vasc Biol 2010 Dec;30(12):2408-15       23 Citations
2Platelet endothelial cell adhesion molecule-1 regulates collagen-stimulated platelet function by modulating the association of phosphatidylinositol 3-kinase with Grb-2-associated binding protein-1 and linker for activation of T cells. (Moraes LA, Barrett NE, Jones CI, Holbrook LM, Spyridon M, Sage T, Newman DK, Gibbins JM) J Thromb Haemost 2010 Nov;8(11):2530-41       44 Citations
2PECAM-1 functions as a negative regulator of laminin-induced platelet activation. (Crockett J, Newman DK, Newman PJ) J Thromb Haemost 2010 Jul;8(7):1584-93       19 Citations
1Novel and unexpected clearance mechanisms for cold platelets. (Rumjantseva V, Hoffmeister KM) Transfus Apher Sci 2010 Feb;42(1):63-70       96 Citations
1Non-redundant roles of phosphoinositide 3-kinase isoforms alpha and beta in glycoprotein VI-induced platelet signaling and thrombus formation. (Gilio K, Munnix IC, Mangin P, Cosemans JM, Feijge MA, van der Meijden PE, Olieslagers S, Chrzanowska-Wodnicka MB, Lillian R, Schoenwaelder S, Koyasu S, Sage SO, Jackson SP, Heemskerk JW) J Biol Chem 2009 Dec 04;284(49):33750-62       118 Citations
3Eptifibatide-induced thrombocytopenia and thrombosis in humans require FcgammaRIIa and the integrin beta3 cytoplasmic domain. (Gao C, Boylan B, Bougie D, Gill JC, Birenbaum J, Newman DK, Aster RH, Newman PJ) J Clin Invest 2009 Mar;119(3):504-11       58 Citations
1Deficiency of LRP8 in mice is associated with altered platelet function and prolonged time for in vivo thrombosis. (Robertson JO, Li W, Silverstein RL, Topol EJ, Smith JD) Thromb Res 2009 Feb;123(4):644-52       26 Citations
2Identification of FcgammaRIIa as the ITAM-bearing receptor mediating alphaIIbbeta3 outside-in integrin signaling in human platelets. (Boylan B, Gao C, Rathore V, Gill JC, Newman DK, Newman PJ) Blood 2008 Oct 01;112(7):2780-6       169 Citations
1A specific CD36-dependent signaling pathway is required for platelet activation by oxidized low-density lipoprotein. (Chen K, Febbraio M, Li W, Silverstein RL) Circ Res 2008 Jun 20;102(12):1512-9       171 Citations
1Platelet CD36 mediates interactions with endothelial cell-derived microparticles and contributes to thrombosis in mice. (Ghosh A, Li W, Febbraio M, Espinola RG, McCrae KR, Cockrell E, Silverstein RL) J Clin Invest 2008 May;118(5):1934-43       153 Citations
1Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. (Patel-Hett S, Richardson JL, Schulze H, Drabek K, Isaac NA, Hoffmeister K, Shivdasani RA, Bulinski JC, Galjart N, Hartwig JH, Italiano JE Jr) Blood 2008 May 01;111(9):4605-16       134 Citations
2Platelet CD36 links hyperlipidemia, oxidant stress and a prothrombotic phenotype. (Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL) Nat Med 2007 Sep;13(9):1086-95       441 Citations
1Heparin-induced thrombocytopenia associated with fondaparinux. (Warkentin TE, Maurer BT, Aster RH) N Engl J Med 2007 Jun 21;356(25):2653-5; discussion 2653-5       249 Citations
3Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. (Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, Cooley BC, Desai D, Morateck PA, Gorski J, Montgomery RR) J Clin Invest 2006 Jul;116(7):1974-82       164 Citations
1The interaction of thrombin with blood platelets. (Lundblad RL, White GC 2nd) Platelets 2005 Nov;16(7):373-85       52 Citations
1Heparin-independent activation of platelets by HIT antibodies: a clue to the etiology of delayed thrombocytopenia/thrombosis in patients given heparin? (Aster RH) J Thromb Haemost 2005 Oct;3(10):2166-7       10 Citations
1Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII. (Yarovoi H, Nurden AT, Montgomery RR, Nurden P, Poncz M) Blood 2005 Jun 15;105(12):4674-6       33 Citations
4Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface. (Boylan B, Chen H, Rathore V, Paddock C, Salacz M, Friedman KD, Curtis BR, Stapleton M, Newman DK, Kahn ML, Newman PJ) Blood 2004 Sep 01;104(5):1350-5       147 Citations
3PECAM-1 negatively regulates GPIb/V/IX signaling in murine platelets. (Rathore V, Stapleton MA, Hillery CA, Montgomery RR, Nichols TC, Merricks EP, Newman DK, Newman PJ) Blood 2003 Nov 15;102(10):3658-64       79 Citations
2Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. (Newman PJ, Newman DK) Arterioscler Thromb Vasc Biol 2003 Jun 01;23(6):953-64       368 Citations
2Mechanisms and implications of platelet discoid shape. (Italiano JE Jr, Bergmeier W, Tiwari S, Falet H, Hartwig JH, Hoffmeister KM, André P, Wagner DD, Shivdasani RA) Blood 2003 Jun 15;101(12):4789-96       147 Citations
1Plasma membrane Ca2+-ATPase isoform 4b is phosphorylated on tyrosine 1176 in activated human platelets. (Wan TC, Zabe M, Dean WL) Thromb Haemost 2003 Jan;89(1):122-31       31 Citations
2The clearance mechanism of chilled blood platelets. (Hoffmeister KM, Felbinger TW, Falet H, Denis CV, Bergmeier W, Mayadas TN, von Andrian UH, Wagner DD, Stossel TP, Hartwig JH) Cell 2003 Jan 10;112(1):87-97       407 Citations
2Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants. (Michaud SE, Wang LZ, Korde N, Bucki R, Randhawa PK, Pastore JJ, Falet H, Hoffmeister K, Kuuse R, Uibo R, Herod J, Sawyer E, Janmey PA) Thromb Res 2002 Sep 01;107(5):245-54       32 Citations
1Heparin is not required for detection of antibodies associated with heparin-induced thrombocytopenia/thrombosis. (Visentin GP, Moghaddam M, Beery SE, McFarland JG, Aster RH) J Lab Clin Med 2001 Jul;138(1):22-31       122 Citations
2Platelet endothelial cell adhesion molecule-1 serves as an inhibitory receptor that modulates platelet responses to collagen. (Patil S, Newman DK, Newman PJ) Blood 2001 Mar 15;97(6):1727-32       148 Citations
1Platelet activation by a relapsing fever spirochaete results in enhanced bacterium-platelet interaction via integrin alphaIIbbeta3 activation. (Alugupalli KR, Michelson AD, Barnard MR, Robbins D, Coburn J, Baker EK, Ginsberg MH, Schwan TG, Leong JM) Mol Microbiol 2001 Jan;39(2):330-40       42 Citations
1Roles of SLP-76, phosphoinositide 3-kinase, and gelsolin in the platelet shape changes initiated by the collagen receptor GPVI/FcR gamma-chain complex. (Falet H, Barkalow KL, Pivniouk VI, Barnes MJ, Geha RS, Hartwig JH) Blood 2000 Dec 01;96(12):3786-92       50 Citations
1Tyrosine phosphorylation and association of FcgammaRII and p72(Syk) are not limited to the FcgammaRII signalling pathway. (Pain S, Falet H, Saci A, Bachelot-Loza C, Rendu F) Cell Signal 2000 Mar;12(3):165-71       15 Citations
1Calpain controls the balance between protein tyrosine kinase and tyrosine phosphatase activities during platelet activation. (Pain S, Monstero-Lastres A, Falet H, Brohard-Bohn B, Fraiz N, Bachelot-Loza C, Cano E, Rendu F) FEBS Lett 1999 Jun 18;453(1-2):119-23       7 Citations
1Determination of heparin-induced thrombocytopenia: a rapid flow cytometric assay for direct demonstration of antibody-mediated platelet activation. (Tomer A, Masalunga C, Abshire TC) Am J Hematol 1999 May;61(1):53-61       52 Citations
1Tyrosine unphosphorylated platelet SHP-1 is a substrate for calpain. (Falet H, Pain S, Rendu F) Biochem Biophys Res Commun 1998 Nov 09;252(1):51-5       23 Citations
1The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation: comparison with thrombin. (Si-Tahar M, Renesto P, Falet H, Rendu F, Chignard M) Biochem J 1996 Jan 15;313 ( Pt 2)(Pt 2):401-8       34 Citations
1Different abilities of thrombin receptor activating peptide and thrombin to induce platelet calcium rise and full release reaction. (Lasne D, Donato J, Falet H, Rendu F) Thromb Haemost 1995 Nov;74(5):1323-8       23 Citations
1Thrombosis and inflammation as multicellular processes: significance of cell-cell interactions. (Marcus AJ, Safier LB, Broekman MJ, Islam N, Fliessbach JH, Hajjar KA, Kaminski WE, Jendraschak E, Silverstein RL, von Schacky C) Thromb Haemost 1995 Jul;74(1):213-7       75 Citations
1Principles of thromboregulation: control of platelet reactivity in vascular disease. (Marcus AJ, Safier LB, Kaminski WE, Islam N, Hajjar KA, Jendraschak E, Silverstein RL, Broekman MJ, von Schacky C, Fliessbach JH) Adv Prostaglandin Thromboxane Leukot Res 1995;23:413-8       9 Citations
1Calcium mobilisation controls tyrosine protein phosphorylation independently of the activation of protein kinase C in human platelets. (Falet H, Rendu F) FEBS Lett 1994 May 23;345(1):87-91       20 Citations
1Cytoskeletal interactions of Rap1b in platelets. (White GC 2nd, Crawford N, Fischer TH) Adv Exp Med Biol 1993;344:187-94       11 Citations
1Identification of lysosome-associated membrane protein-2 as an activation-dependent platelet surface glycoprotein. (Silverstein RL, Febbraio M) Blood 1992 Sep 15;80(6):1470-5       84 Citations
1Production of platelet thromboxane A2 and arterial prostacyclin I2 from hypercholesterolemic rats. (Arnold JH, Pritchard KA Jr, Greco NJ, Panganamala RV) Prostaglandins Leukot Essent Fatty Acids 1992 Jul;46(3):215-7       4 Citations
1rap1B, a cAMP-dependent protein kinase substrate, associates with the platelet cytoskeleton. (Fischer TH, Gatling MN, Lacal JC, White GC 2nd) J Biol Chem 1990 Nov 15;265(32):19405-8       83 Citations
1Identification and characterization of LAMP-1 as an activation-dependent platelet surface glycoprotein. (Febbraio M, Silverstein RL) J Biol Chem 1990 Oct 25;265(30):18531-7       94 Citations